173 related articles for article (PubMed ID: 19618298)
21. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
[TBL] [Abstract][Full Text] [Related]
22. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
[TBL] [Abstract][Full Text] [Related]
23. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
24. Systemic treatment of a metastatic carotid body tumor: A case report and literature review.
Xing J; Cheng Y; Ying H; Guan M; Jia N; Bai C
Medicine (Baltimore); 2020 Nov; 99(47):e22811. PubMed ID: 33217796
[TBL] [Abstract][Full Text] [Related]
25. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
27. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K
Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086
[TBL] [Abstract][Full Text] [Related]
28. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
[TBL] [Abstract][Full Text] [Related]
29. A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene.
Drucker AM; Houlden RL
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):702-6; quiz following 706. PubMed ID: 17143317
[TBL] [Abstract][Full Text] [Related]
30. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
Goffredo P; Sosa JA; Roman SA
J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
[TBL] [Abstract][Full Text] [Related]
32.
Fishbein L; Ben-Maimon S; Keefe S; Cengel K; Pryma DA; Loaiza-Bonilla A; Fraker DL; Nathanson KL; Cohen DL
Endocr Relat Cancer; 2017 Aug; 24(8):L51-L55. PubMed ID: 28566531
[No Abstract] [Full Text] [Related]
33. Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.
Ghayee HK; Havekes B; Corssmit EP; Eisenhofer G; Hammes SR; Ahmad Z; Tessnow A; Lazúrová I; Adams KT; Fojo AT; Pacak K; Auchus RJ
Endocr Relat Cancer; 2009 Mar; 16(1):291-9. PubMed ID: 19075037
[TBL] [Abstract][Full Text] [Related]
34. Metastatic paraganglioma.
Fliedner SM; Lehnert H; Pacak K
Semin Oncol; 2010 Dec; 37(6):627-37. PubMed ID: 21167381
[TBL] [Abstract][Full Text] [Related]
35. [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
Naoi Y; Tamaki Y; Ooka M; Tsukamoto F; Miyoshi Y; Tanji Y; Taguchi T; Noguchi S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):145-9. PubMed ID: 12557721
[TBL] [Abstract][Full Text] [Related]
36. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
[TBL] [Abstract][Full Text] [Related]
37. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
38. Metastatic pheochromocytoma and paraganglioma.
Angelousi A; Kassi E; Zografos G; Kaltsas G
Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
[TBL] [Abstract][Full Text] [Related]
39. Somatic SDHA mutations in paragangliomas in siblings: Case report of 2 cases.
Huang YC; Chang HH; Chen MH; Huang KH; Li AF; Lin CH; Shyr YM; Fang WL
Medicine (Baltimore); 2020 Oct; 99(41):e22497. PubMed ID: 33031286
[TBL] [Abstract][Full Text] [Related]
40. Succinate dehydrogenase subunit D and succinate dehydrogenase subunit B mutation analysis in canine phaeochromocytoma and paraganglioma.
Holt DE; Henthorn P; Howell VM; Robinson BG; Benn DE
J Comp Pathol; 2014 Jul; 151(1):25-34. PubMed ID: 24813157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]